Your browser doesn't support javascript.
loading
The targeted histone deacetylase inhibitor tefinostat (CHR-2845) shows selective in vitro efficacy in monocytoid-lineage leukaemias.
Zabkiewicz, Joanna; Gilmour, Marie; Hills, Robert; Vyas, Pares; Bone, Elizabeth; Davidson, Alan; Burnett, Alan; Knapper, Steven.
Afiliación
  • Zabkiewicz J; Department of Haematology, Experimental Cancer Medicine Centre (ECMC), Institute of Cancer and Genetics, School of Medicine, Cardiff University, Cardiff, UK.
  • Gilmour M; Department of Haematology, Experimental Cancer Medicine Centre (ECMC), Institute of Cancer and Genetics, School of Medicine, Cardiff University, Cardiff, UK.
  • Hills R; Department of Haematology, Experimental Cancer Medicine Centre (ECMC), Institute of Cancer and Genetics, School of Medicine, Cardiff University, Cardiff, UK.
  • Vyas P; Weatherall Institute of Molecular Medicine, University of Oxford, Oxford, UK.
  • Bone E; Chroma Therapeutics, Abingdon, UK.
  • Davidson A; Chroma Therapeutics, Abingdon, UK.
  • Burnett A; Department of Haematology, Experimental Cancer Medicine Centre (ECMC), Institute of Cancer and Genetics, School of Medicine, Cardiff University, Cardiff, UK.
  • Knapper S; Department of Haematology, Experimental Cancer Medicine Centre (ECMC), Institute of Cancer and Genetics, School of Medicine, Cardiff University, Cardiff, UK.
Oncotarget ; 7(13): 16650-62, 2016 Mar 29.
Article en En | MEDLINE | ID: mdl-26934551

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Leucemia Mieloide / Inhibidores de Histona Desacetilasas / Ácidos Hidroxámicos / Anilidas / Nucleotidiltransferasas Límite: Humans Idioma: En Revista: Oncotarget Año: 2016 Tipo del documento: Article País de afiliación: Reino Unido

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Leucemia Mieloide / Inhibidores de Histona Desacetilasas / Ácidos Hidroxámicos / Anilidas / Nucleotidiltransferasas Límite: Humans Idioma: En Revista: Oncotarget Año: 2016 Tipo del documento: Article País de afiliación: Reino Unido